Metoclopramide response in patients with early diffuse systemic sclerosis. Effects on esophageal motility abnormalities

Clinical and Experimental Rheumatology

Volumn 23, Issue 5, 2005, Pages 685-688

  Mercado, Ulises ^a,b   Arroyo de Anda, R ^a   Avendano L ^a   Araiza Casillas, R ^a   Avendano Reyes M ^a  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^b NONE   (United States)

Author keywords

Esophageal motility; Esophagus; Manometry; Metoclopramide diffuse systemic sclerosis

Indexed keywords

METOCLOPRAMIDE;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG RESPONSE; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PERISTALSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC SCLEROSIS;

ADULT; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGEAL SPHINCTER, LOWER; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METOCLOPRAMIDE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 24944464275     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. SCOBEY MW, CASTELL DO: Secondary esophageal motility disorders. In CASTELL DO (Ed.): Esophageal Motility Testing. New York, Elsevier 1987: 172-8.
2. FITZGERALD RC, TRIADAFILOPOULOS G: Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum 1997;26:641-66.
3. MASI AT, RODNAN GP, MEDSGER TA Jr et al.: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
4. LEROY CE, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis). Classification, subset and pathogenesis. J Rheumatol 1988; 15: 202-5.
5. KLEIN HA, WALD A, GRAHAM TO et al.: Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 1992; 102: 1551-6.
6. CLEMENTS PJ, BECVAR R, DROSOS AA et al.: Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003; 21 (Suppl. 29): S-15-S18.
7. LIN HC, HASLER WL: Disorders of gastric emptying. In YAMADA T (Ed.): Textbook of Gastroenterology. Philadelphia, J.B. Lippincot Co. 1995: 1318-46.
8. JOHNSON DA, DRANE WE, CURRAN J et al.: Metolopramide response in patients with progressive systemic sclerosis. Arch Intern Med 1987; 147: 1597-601.
9. MYERS AR: Progressive systemic sclerosis: Gastrointestinal involvement. Clin Rheum Dis 1979; 5: 115-29.
10. RAMIREZ-MATA M, IBAÑEZ G, ALARCÓN-SEGOVIA D: Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients with PSS. Arthritis Rheum 1977; 20: 30-4.
11. GILLILAND B: Systemic sclerosis (scleroderma) and related disorders. In KASPER DL, BRAUNWALD E, FAUCI AS et al. (Eds.); Harrison's Principles of Internal Medicine. 16th ed. New York; MacGraw-Hill; 2005: 1979-1990.